Transfer of endogenous pyrogens across artificial membranes?
Synthetic high-flux dialyzer membranes used in continuous veno-venous hemofiltration are permeable to middle molecular size endogenous pyrogens, the pro-inflammatory cytokines IL-1 beta and TNF-alpha. The quantities removed by sieving are, however, negligible in vitro as well as in vivo. Adsorption of cytokines to the membrane polymer is the major mechanism of pyrogen removal. Adsorption seems to be semispecific for pro-inflammatory cytokines because levels of anti-inflammatory mediators were not changed or even increased during CVVH. Thus, CVVH may change cytokine profiles in septic patients supporting the predominance of anti-inflammatory over pro-inflammatory activity in plasma. It remains to be demonstrated whether modifications of extracorporeal blood purification systems (high-volume CVVH, plasma separation + adsorption) are able to amplify the change in cytokine profiles and whether this change influences outcome of septic patients.
Lonnemann
G
G
Department of Nephrology, Medizinische Hochschule Hannover, Germany.
Linnenweber
S
S
Burg
M
M
Koch
K M
KM
D058186:Acute Kidney Injury / Q000097:blood / Q000628:therapy; D016207:Cytokines / Q000097:blood / Q000493:pharmacokinetics; D005112:Extracorporeal Circulation; D006440:Hemofiltration; D006801:Humans; D066298:In Vitro Techniques; D018836:Inflammation Mediators / Q000493:pharmacokinetics; D007375:Interleukin-1 / Q000493:pharmacokinetics; D008567:Membranes, Artificial; D011749:Pyrogens / Q000493:pharmacokinetics*; D006435:Renal Dialysis; D017582:Renal Replacement Therapy; D018746:Systemic Inflammatory Response Syndrome / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha / Q000493:pharmacokinetics
D016207:Cytokines; D018836:Inflammation Mediators; D007375:Interleukin-1; D008567:Membranes, Artificial; D011749:Pyrogens; D014409:Tumor Necrosis Factor-alpha